Home > Drug Search >
  • company_query: Austin Research Institute
  •   > 
Drug Filter
Category:
chemistry (10) biology (26)
Status:
Approved (1) BLA Filing (1) Phase Ⅲ (14) Phase Ⅱ (12) Phase Ⅰ (8)
Clinical Stage:
Pending (6) Active (27) Discontinued (2)
Bio-Type:
Gene therapy (1) Vaccine (16) Blood extraction (1) Recombinant polypeptide (1) Recombinant cytokines (1) Recombinant hormone (1) Other recombinant protein (1) Whole antibody (2) Fusion protein (1)
Indication:
Meningitis (1) Atopic dermatitis (1) Breast cancer (2) Chronic obstructive pulmonary disease (COPD) (1) Friedreich's ataxia (1) HBV infection (1) HCV infection (1) HIV infection (4) Hypertriglyceridemia (1) Rabies (1) Malignancies (1) Multiple sclerosis (MS) (1) Myocardial infarction (MI) (1) Osteoporosis (1) Haemophilus infection (2) Prostate cancer (1) Rheumatoid arthritis (RA) (2) Solid tumours (1) Tuberculosis (1) Ulcerative colitis (2) Retinal dystrophies (1) Cervical intraepithelial neoplasia (1) Influenza A virus infections (1) Varicose ulcer (1) Neonatal respiratory distress syndrome (1) Stroke (1) Type 1 diabetes (1) Neutropenia (1) Condylomata acuminata (1) Renal carcinoma (1) Pressure sore (1) Hepatic fibrosis (1) Graft versus host disease (1) Plaque psoriasis (2) Allergic asthma (1) Hemorrhoids (1) Muscular atrophy (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top